4.7 Article

Id2 represses E2A-mediated activation of IL-10 expression in T cells

期刊

BLOOD
卷 123, 期 22, 页码 3420-3428

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2014-03-561456

关键词

-

资金

  1. National Health and Medical Research Council of Australia (NHMRC) [APP1042582]
  2. Australian Research Council
  3. Leukemia Foundation of Australia
  4. Victorian Cancer Agency
  5. Victorian State Government Operational Infrastructure Support
  6. Australian Government NHMRC IRIIS

向作者/读者索取更多资源

Interleukin-10 (IL-10) is a key immunoregulatory cytokine that functions to prevent inflammatory and autoimmune diseases. Despite the critical role for IL-10 produced by effector CD8(+) T cells during pathogen infection and autoimmunity, the mechanisms regulating its production are poorly understood. We show that loss of the inhibitor of DNA binding 2 (Id2) in T cells resulted in aberrant IL-10 expression in vitro and in vivo during influenza virus infection and in a model of acute graft-versus-host disease (GVHD). Furthermore, IL-10 overproduction substantially reduced the immunopathology associated with GVHD. We demonstrate that Id2 acts to repress the E2A-mediated transactivation of the Il10 locus. Collectively, our findings uncover a key regulatory role of Id2 during effector T cell differentiation necessary to limit IL-10 production by activated T cells and minimize their suppressive activity during the effector phase of disease control.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据